Identifying the causes of cardiac arrest which can be reversed using ultrasound
Phase 3
- Conditions
- Health Condition 1: I468- Cardiac arrest due to other underlying condition
- Registration Number
- CTRI/2023/08/056475
- Lead Sponsor
- IMS and SUM hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult patients who sustained in- hospital cardiac arrest (IHCA) will be included in the study
Exclusion Criteria
Trauma patients, end stage malignancy and patinets in whom performing USG is not amenable will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Point of care ultrasound as guide to identify the reversible causes of cardiac arrestTimepoint: 1 day
- Secondary Outcome Measures
Name Time Method Glassgow outcome scores (GOS) among the survivorsTimepoint: immediately & after 3 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does transthoracic ultrasound identify in reversible cardiac arrest scenarios?
How does sonological transthoracic assessment compare to ACLS protocols in identifying reversible cardiac arrest causes?
What biomarkers correlate with successful reversal of cardiac arrest using ReSTAT ultrasound protocol in CTRI/2023/08/056475?
What are the potential adverse events associated with sonological transthoracic assessment in cardiac arrest patients?
How does ReSTAT ultrasound compare to other imaging modalities in diagnosing reversible cardiac arrest causes?